Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 15, 1998BloodOpen Access

Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes for the Treatment of Patients With EBV-Positive Relapsed Hodgkin's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMarie RoskrowUniversity of LondonNSNobuhiro SuzukiOkayama University of ScienceYGYan-jun Gan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Roskrow et al. (1998) studied this question.

synapsesocial.com/papers/6a745dfd3e32726c44092e5ahttps://doi.org/10.1182/blood.v91.8.2925.2925_2925_2934
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD281996 · 88 citations
  2. 2Epstein-Barr virus in AIDS-related primary central nervous system lymphoma1991 · 522 citations
  3. 3Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes1992 · 248 citations